Singapore markets open in 8 hours 45 minutes

GSK plc (GLAXF)

Other OTC - Other OTC Delayed price. Currency in USD
Add to watchlist
19.850.00 (0.00%)
As of 09:50AM EDT. Market open.
Full screen
Trade prices are not sourced from all markets
Previous close19.85
Open19.85
Bid0.00 x 0
Ask0.00 x 0
Day's range19.85 - 19.85
52-week range16.65 - 22.12
Volume165
Avg. volume1,314
Market cap83.31B
Beta (5Y monthly)0.27
PE ratio (TTM)13.41
EPS (TTM)N/A
Earnings dateN/A
Forward dividend & yield0.80 (4.04%)
Ex-dividend date22 Feb 2024
1y target estN/A
  • Insider Monkey

    20 Fastest Growing Health Tech Companies in the World

    In this article, we will be taking a look at the 20 fastest growing health tech companies in the world. If you do not want to learn about the trends in digital health market, head straight to the 5 Fastest Growing Health tech Companies in the World. Explosive Growth and Key Trends in the Digital […]

  • Reuters

    UPDATE 3-GlaxoSmithKline sues Pfizer and BioNTech over Covid-19 vaccine technology

    GlaxoSmithKline sued Pfizer and BioNTech in Delaware federal court on Thursday, accusing them of infringing GSK patents related to messenger RNA (mRNA) technology in the companies' blockbuster COVID-19 vaccines. GSK said in the lawsuit that Pfizer and BioNTech's Comirnaty vaccines violate the company's patent rights in mRNA-vaccine innovations developed "more than a decade before" the outbreak of the COVID-19 pandemic.

  • Reuters

    GlaxoSmithKline sues Pfizer and BioNTech over Covid-19 vaccine technology

    (Reuters) -GlaxoSmithKline sued Pfizer and BioNTech in Delaware federal court on Thursday, accusing them of infringing GSK patents related to messenger RNA (mRNA) technology in the companies' blockbuster COVID-19 vaccines. GSK said in the lawsuit that Pfizer and BioNTech's Comirnaty vaccines violate the company's patent rights in mRNA-vaccine innovations developed "more than a decade before" the outbreak of the COVID-19 pandemic.